"all these GBCAs are approved by FDA at identical administered total doses of 0.1mmol/kg body weight 1"
"Note: This article is intended to outline some general principles of protocol design. The specifics will vary depending on MRI hardware and software, radiologist's and referrer's preference, institutional protocols, patient factors (e.g. allergy) and time constraints. "
"Note: This article is intended to outline some general principles of protocol design. The specifics will vary depending on MRI hardware and software, radiologist's and referrer's preference, institutional protocols, patient factors (e.g. allergy) and time constraints."
"T1 weighted"
"T2 weighted"
"FLAIR"
"diffusion-weighted imaging (DWI)"
"susceptibility weighted imaging (SWI)"
"postcontrast sequences"
"sequence: fast-spin echo (T1 FSE) or gradient (T1 MPRAGE)"
"sequence: T2 FSE"
"sequence: post-contrast fast-spin echo (T1 FSE) or gradient (T1 MPRAGE). A fat-saturated sequence is considered in at least one plane"
"all these GBCAs are approved by FDA at identical administered total doses of 0.1mmol/kg body weight 1"
"Gadolinium-based contrast agents (GBCAs) for CNS 1:"
Expected headings
"Sequences"